DHR · Danaher Corporation

S&P 500 #87 · NYSE

Risiko 4/10 · Life-Science Tools Leader · $199.05 ▲ 1.30%

Kennzahlen

• Price $199.05
• Market cap $139.9B
• P/E (ttm) 35.54
• Div yield 0.81%
• 52-wk range $160.93 – $242.80
• Index rank #87 / —

Wichtigste Risiken

• Biopharma capex cyclicality post-COVID normalization (Biotech customers) — MED
• China revenue exposure to export controls (Global revenue mix) — MED
• Premium valuation leaves limited margin for error (Growth investors) — MED
• Integration risk from ongoing portfolio restructuring (Management/shareholders) — LOW

Fazit

High-quality life-science and diagnostic instruments platform leveraging the Danaher Business System; post-spin refocus on bioprocessing, diagnostics, and water quality.

Interaktive Analyse öffnen → Teilen

Recherche, keine Anlageberatung.